Joshua R. Disbrow
2018 - AYTU BIOPHARMA
In 2018, Joshua R. Disbrow earned a total compensation of $606K as Chief Executive Officer at AYTU BIOPHARMA, a 42% decrease compared to previous year.
Compensation breakdown
| Salary | $303,000 |
|---|---|
| Stock Awards | $303,000 |
| Total | $606,000 |
Disbrow received $303K in salary, accounting for 50% of the total pay in 2018.
Disbrow also received $303K in stock awards.
Rankings
In 2018, Joshua R. Disbrow's compensation ranked 11,248th out of 14,244 executives tracked by ExecPay. In other words, Disbrow earned more than 21.0% of executives.
| Classification | Ranking | Percentile |
|---|---|---|
All | 11,248 out of 14,244 | 21st |
Division Manufacturing | 4,549 out of 5,759 | 21st |
Major group Chemicals And Allied Products | 1,722 out of 2,122 | 19th |
Industry group Drugs | 1,462 out of 1,811 | 19th |
Industry Pharmaceutical Preparations | 1,122 out of 1,385 | 19th |
Source: SEC filing on February 25, 2019.
Disbrow's colleagues
We found five more compensation records of executives who worked with Joshua R. Disbrow at AYTU BIOPHARMA in 2018.
News
AYTU BIOPHARMA CEO Joshua Disbrow's 2023 pay rises 20% to $708K
May 10, 2024
AYTU BIOPHARMA CEO Joshua Disbrow's 2021 pay jumps 291% to $6.2M
April 7, 2022
AYTU BIOPHARMA CEO Joshua Disbrow's 2020 pay jumps 52% to $1.6M
April 16, 2021
AYTU BIOPHARMA CEO Joshua Disbrow's 2019 pay jumps 72% to $1M
March 5, 2020
AYTU BIOPHARMA CEO Joshua Disbrow's 2018 pay falls 42% to $606K
February 25, 2019